BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28954901)

  • 1. Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.
    Peterson LR; Young SA; Davis TE; Wang ZX; Duncan J; Noutsios C; Liesenfeld O; Osiecki JC; Lewinski MA
    J Clin Microbiol; 2017 Dec; 55(12):3426-3436. PubMed ID: 28954901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Active Surveillance Testing for Clostridium difficile Colonization Using the cobas Cdiff Test.
    Patel PA; Schora DM; Singh K; Peterson LR
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367295
    [No Abstract]   [Full Text] [Related]  

  • 3. Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection.
    Granato PA; Hansen G; Herding E; Chaudhuri S; Tang S; Garg SK; Rowell CR; Sickler JJ
    PLoS One; 2018; 13(7):e0200498. PubMed ID: 30040852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.
    Pancholi P; Kelly C; Raczkowski M; Balada-Llasat JM
    J Clin Microbiol; 2012 Apr; 50(4):1331-5. PubMed ID: 22278839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular test based on isothermal helicase-dependent amplification for detection of the Clostridium difficile toxin A gene.
    Eckert C; Holscher E; Petit A; Lalande V; Barbut F
    J Clin Microbiol; 2014 Jul; 52(7):2386-9. PubMed ID: 24759714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.
    Stamper PD; Alcabasa R; Aird D; Babiker W; Wehrlin J; Ikpeama I; Carroll KC
    J Clin Microbiol; 2009 Feb; 47(2):373-8. PubMed ID: 19073875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.
    Stellrecht KA; Espino AA; Maceira VP; Nattanmai SM; Butt SA; Wroblewski D; Hannett GE; Musser KA
    J Clin Microbiol; 2014 May; 52(5):1423-8. PubMed ID: 24554744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.
    Shin BM; Yoo SM; Shin WC
    Ann Lab Med; 2016 Mar; 36(2):131-7. PubMed ID: 26709260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a nucleic acid amplification assay for the diagnosis of Clostridioides difficile infection.
    Koyuncu-Ozyurt O; Ozhak B; Ogunc D; Ongut G; Gunseren F; Donmez L; Colak D
    Anaerobe; 2019 Oct; 59():201-204. PubMed ID: 31255716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance Comparison of a Novel Rapid Stand-alone Molecular Test and a 2-Step Diagnostic Algorithm for Clostridioides difficile Detection in Children.
    Brotons P; Saucedo J; Simó S; Gené A; Muñoz-Almagro C
    Pediatr Infect Dis J; 2021 Feb; 40(2):169-172. PubMed ID: 33055503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Liat Cdiff Assay for Direct Detection of Clostridioides difficile Toxin Genes within 20 Minutes.
    Hetem DJ; Bos-Sanders I; Nijhuis RHT; Tamminga S; Berlinger L; Kuijper EJ; Sickler JJ; Claas ECJ
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30944191
    [No Abstract]   [Full Text] [Related]  

  • 14. A Multicenter Study of the Revogene C. difficile System for Detection of the Toxin B Gene from Unformed Stool Specimens.
    Mashock MJ; Faron ML; Carroll KC; Dang C; Lewis S; Salimnia H; Lephart P; Loo VG; Schmitt BH; Young S; Buchan BW; Ledeboer NA
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776191
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens.
    Buchan BW; Mackey TL; Daly JA; Alger G; Denys GA; Peterson LR; Kehl SC; Ledeboer NA
    J Clin Microbiol; 2012 Dec; 50(12):3932-6. PubMed ID: 23015667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.
    Boyanton BL; Sural P; Loomis CR; Pesta C; Gonzalez-Krellwitz L; Robinson-Dunn B; Riska P
    J Clin Microbiol; 2012 Mar; 50(3):640-5. PubMed ID: 22189114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing Clostridioides difficile infections with molecular diagnostics: multicenter evaluation of revogene C. difficile assay.
    Sambri V; Gateau C; Zannoli S; Dirani G; Couturier J; Op den Buijs I; Roymans R; Hallet E; Arnold M; Zumoberhaus A; Steiner S; van de Bovenkamp J; Altwegg M; Berlinger L; Barbut F;
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1169-1175. PubMed ID: 32062723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture.
    Jensen MB; Olsen KE; Nielsen XC; Hoegh AM; Dessau RB; Atlung T; Engberg J
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):727-36. PubMed ID: 25421216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of BD Max Cdiff and GenomEra C. difficile molecular assays for detection of toxigenic Clostridium difficile from stools in conventional sample containers and in FecalSwabs.
    Hirvonen JJ; Kaukoranta SS
    Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):1005-9. PubMed ID: 25616552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay.
    Carroll KC; Buchan BW; Tan S; Stamper PD; Riebe KM; Pancholi P; Kelly C; Rao A; Fader R; Cavagnolo R; Watson W; Goering RV; Trevino EA; Weissfeld AS; Ledeboer NA
    J Clin Microbiol; 2013 Dec; 51(12):4120-5. PubMed ID: 24088862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.